2019

London, UK

The Complement-based Drug Development Summit Europe is the first industry-dedicated meeting focused on optimizing clinical trial design, efficacy assessment, target identification and expansion beyond orphan diseases.

Across 3 content-packed days, the field’s thought leaders from Alexion, Akari, Novartis, Complement Pharma and many more will be sharing their insight and lessons learned, collectively enabling the community to:

  • Analysing Points of Inhibition: Assess the most effective points of complement inhibition for the treatment of individual diseases and the selection of therapeutic approaches for inhibition.
  • Optimise Clinical Trial Design: Fine-tune clinical trial design for expansion beyond orphan diseases, advancing patient stratification, targeting, dosing, endpoints and sample handling.
  • Standardising Efficacy Assessment: Define the next steps toward achieving standardisation of robust, functional assays in order to accurately determine treatment efficacy.
  • Advancing Safety Profiles: Ensure patient safety by enhancing the management of off-target effects and approaches for minimising infection risk.
  • Navigating the Regulatory Landscape: Streamline the regulatory approval process by examining guidelines and expectations, ensuring that drugs reach the market smoothly.

Join the Complement-based Drug Development Summit Europe to build the scaffold upon which complement therapeutics can be expanded beyond the treatment of ultra-rare diseases.

Testimonials from our Past Events in the Cell and Viral Immunotherapy Space:

“Overall an excellent programme with topical presentations and great opportunities to network with leaders in the field. The fact that it was a relatively small meeting with high level people made such interactions possible and made it hugely valuable.” Past CVI Summit Attendee, Virttu Biologics

“This was an amazing meeting with a terrific turnout and engagement by industry. The advances in technology being made and the issues being addressed were extremely eye-opening.” Past CVI Summit Attendee, Prescient Healthcare

“This meeting gathered all experts in the field to share ideas and data. It was quite an eye opener. I feel I came home with excitement and a brand new mind towards my work in the field.” Past CVI Summit Attendee, Pfizer

in association